ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients

Abstract Background Breast malignancies are the predominant cancer-related cause of death in women. New methods of diagnosis, prognosis and treatment are necessary. Previously, we identified the breast cancer cell surface protein ADAM8 as a marker of poor survival, and a driver of Triple-Negative Br...

Descripció completa

Dades bibliogràfiques

Autors principals:	Stefania Pianetti, Kathy D. Miller, Hannah H. Chen, Sandra Althouse, Sha Cao, Steven J. Michael, Gail E. Sonenshein, Nora D. Mineva
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2023-08-01
Col·lecció:	Cancer Cell International
Matèries:	ADAM8 Breast cancer Biomarker Immunohistochemistry Diagnosis Prognosis
Accés en línia:	https://doi.org/10.1186/s12935-023-03024-3
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!